THURSDAY, May 8, 2025 (HealthDay News) — Fast food and ready-made packaged eats could be doing slow damage to people’s brains. Ultra-processed foods like breakfast cereals, soft drinks, hot dogs and ketchup appear to increase a person’s risk of developing Parkinson’s disease, a new study says. People who ate aboutContinue Reading
THURSDAY, May 1, 2025 (HealthDay News) — A class of drugs used to treat epilepsy, nerve pain and anxiety do not appear to increase a person’s risk of self-harm, a major new study says. Gabapentinoids – which include gabapentin and pregabalin – have been associated with an increased risk ofContinue Reading
THURSDAY, April 17, 2025 (HealthDay News) — Common medications like aspirin, ibuprofen, statins and beta blockers appear to slow the progress of Parkinson’s disease, a new study says. Parkinson’s symptoms took nearly a decade longer to crop up in patients taking these drugs to treat pain, high blood pressure, diabetesContinue Reading
MONDAY, March 17, 2025 (HealthDay News) — The blues and the jitters are very common among people battling chronic pain, a new evidence review says. About 40% of adults with chronic pain have symptoms of depression or anxiety, researchers report in JAMA Network Open. Women, younger adults and people sufferingContinue Reading
FRIDAY, March 7, 2025 (HealthDay News) — The number of people with Parkinson’s disease will more than double by 2050, driven by the aging of the global population, a new study suggests. In all, 25.2 million people will be living with Parkinson’s by 2050, researchers project in The BMJ. “AnContinue Reading
MONDAY, March 3, 2025 — A patient with multiple autoimmune diseases can remember the exact moment a doctor tore their heart out. “One doctor told me I was making myself feel pain, and I still can’t forget those words,” the patient remembered. “Telling me I’m doing it to myself hasContinue Reading
WEDNESDAY, Feb. 19, 2025 (HealthDay News) — Lupus can do irreversible harm to a person’s organs, damaging the lungs, kidneys, heart, liver and other vital organs through inflammation. But a newer lupus drug appears to protect patients from much of this organ damage, a new study suggests. Anifrolumab (brand nameContinue Reading
Onapgo is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced diseaseContinue Reading
WEDNESDAY, Feb. 5, 2025 (HealthDay News) — Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson’s disease have taken an hit. A new study found that a drug in the same class called exenatide, marketed as Byetta, had no effect on slowing the disease or easingContinue Reading
WEDNESDAY, Jan. 15, 2024 (HealthDay News) — People with lupus-related skin problems are more likely to develop heart disease associated with hardening of the arteries. Lupus patients with skin symptoms are 72% more likely to develop atherosclerotic heart disease, in which arteries become clogged and less flexible, researchers reported inContinue Reading